Kazazian Asset Management, LLC Cytokinetics Inc Call Options Transaction History
Kazazian Asset Management, LLC
- $123 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
394Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$500 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$404 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$340 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$272 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$208 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.21B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...